On the other hand, it has been reported that COVID-19 patients show a prominent downregulation of ACE2 expression in the vascular endothelium, accompanied by immune infiltration and myocardial fibrosis (Bois et al., 2021; Wang et al., 2022a). Here, ACE2 is linked to COVID-19.